Belite Bio Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 197.56, 439.29, 1026.88, 1459.32 ], "ebit_estimate": [ -143.54, -31.36, 136.2, 471.5, 776.4 ], "ebitda_estimate": [ -56.09, 139.16, 321.76, 896.8, null ], "net_income_estimate": [ -133.01, -25.42, 159.03, 469.22, 709.06 ], "per_share_eps_estimate": [ -3.35, -0.57, 3.88, 10.07, 15.07 ], "eps_nri_estimate": [ -3.29, -0.57, 3.55, 10.07, 15.07 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 17, 17.65, 21.11, null, null ], "pretax_income_estimate": [ -131.28, -25.44, 159.03, 487.63, 805.58 ], "operating_cash_flow_per_share_estimate": [ -2.07, -1.14, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -19.95, 0.18, 14.55, null, null ], "gross_margin_estimate": [ null, 78.43, 82.85, 83.05, 85.6 ], "operating_cash_flow_estimate": [ -82.53, -45.45, null, null, null ], "pettm_estimate": [ 0, 0, 38.5, 14.82, 9.9 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, null, null, 98.75, 25, 62.5, 125 ], "ebit_estimate": [ -33.98, -35.87, -39.04, -51.5, -43.5, -26.5, 6 ], "ebitda_estimate": [ -33.18, -34.02, -36.06, null, null, null, null ], "net_income_estimate": [ -32.06, -34.04, -39.53, -51.5, -43.5, -26.5, 6 ], "per_share_eps_estimate": [ -0.8, -0.84, -0.96, 1.22, -0.78, -0.07, 1.09 ], "eps_nri_estimate": [ -0.79, -0.83, -0.94, 1.22, -0.78, -0.07, 1.09 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -33.07, -35.28, -38.37, -51.5, -43.5, -26.5, 6 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, 71.5, 71.5, 71.5, 71.5 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 102.23, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }